VHCP Management II, LLC current holdings: USA Other Stocks
VHCP Management II, LLC reported $0.14 billion in shares no fund filing gives a ticker for, so this site has no page for them (listed in the US), 18 positions, in its Form 13F for the quarter ended 2016-09-30; the largest are AveXis Inc, Edge Therapeutics Inc, DBV Technologies.
- AveXis Inc: Country of operation —; Class COM; Shares 1,035,657; Value $42,679,000.
- Edge Therapeutics Inc: Country of operation —; Class COM; Shares 1,933,582; Value $20,129,000.
- DBV Technologies: Country of operation —; Class COM; Shares 373,617; Value $19,444,000.
- Ascendis Pharma A/S: Country of operation —; Class COM; Shares 721,152; Value $14,495,000.
Form 13F-HR as filed (SEC CIK 1602263): quarter ended 2016-09-30, filed 2016-11-14. The manager files one row per sub-manager; rows for the same security, class and put/call are added together.
| Stock | Country of operation | Class | Shares | Value | Quarter end | Filed |
|---|
AveXis Inc
CUSIP 05366U100 | | COM | 1,035,657 | $42,679,000 | 2016-09-30 | 2016-11-14 |
|---|
Edge Therapeutics Inc
CUSIP 279870109 | | COM | 1,933,582 | $20,129,000 | 2016-09-30 | 2016-11-14 |
|---|
DBV Technologies
CUSIP F2927N109 | | COM | 373,617 | $19,444,000 | 2016-09-30 | 2016-11-14 |
|---|
Ascendis Pharma A/S
CUSIP 04351P101 | | COM | 721,152 | $14,495,000 | 2016-09-30 | 2016-11-14 |
|---|
Audentes Therapeutics
CUSIP 05070R104 | | COM | 458,882 | $7,267,000 | 2016-09-30 | 2016-11-14 |
|---|
CoLucid Pharmaceuticals
CUSIP 19716T101 | | COM | 159,110 | $6,070,000 | 2016-09-30 | 2016-11-14 |
|---|
Axovant Sciences Ltd
CUSIP G0750W104 | | COM | 429,590 | $6,014,000 | 2016-09-30 | 2016-11-14 |
|---|
Alcobra Ltd
CUSIP M2239P109 | | COM | 1,537,463 | $3,798,000 | 2016-09-30 | 2016-11-14 |
|---|
Stemline Therapeutics Inc
CUSIP 85858C107 | | COM | 315,980 | $3,422,000 | 2016-09-30 | 2016-11-14 |
|---|
Achillion Pharmaceuticals Inc
CUSIP 00448Q201 | | COM | 420,000 | $3,402,000 | 2016-09-30 | 2016-11-14 |
|---|
Akari Therapeutics Plc
CUSIP 00972G108 | | COM | 369,490 | $3,144,000 | 2016-09-30 | 2016-11-14 |
|---|
ARCA biopharma Inc
CUSIP 00211Y100 | | COM | 1,078,932 | $3,053,000 | 2016-09-30 | 2016-11-14 |
|---|
Ocera Therapeutics
CUSIP 67552A108 | | COM | 1,088,372 | $2,873,000 | 2016-09-30 | 2016-11-14 |
|---|
Aeglea BioTherapeutics
CUSIP 00773J103 | United States | COM | 350,133 | $2,235,000 | 2016-09-30 | 2016-11-14 |
|---|
Lipocine Inc
CUSIP 53630X104 | | COM | 420,000 | $1,873,000 | 2016-09-30 | 2016-11-14 |
|---|
Adverum Biotechnologies Inc
CUSIP 00773U108 | | COM | 280,000 | $1,151,000 | 2016-09-30 | 2016-11-14 |
|---|
Zafgen Inc
CUSIP 98885E103 | | COM | 141,479 | $468,000 | 2016-09-30 | 2016-11-14 |
|---|
ProNAI Therapeutics Inc
CUSIP 74346L101 | | COM | 130,798 | $238,000 | 2016-09-30 | 2016-11-14 |
|---|
Similar Firms
| Firm Name | Country | 13F Value | Holdings |
|---|
| Not available yet |